Skip to content
10-K/A

Annual Report

GeneThera, Inc.

0001575872-23-000192

← back to feed
Filed
Feb 1, 2023 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2021 · Apr 13, 2022 34.08M sh
Operating Cash Flow FY 2021 · Dec 31, 2021 −$8.57K
Operating Cash Flow FY 2021 · Dec 31, 2020 −$5.31K
Stockholders Equity FY 2021 · Dec 31, 2021 −$8.17M
Stockholders Equity FY 2021 · Dec 31, 2020 −$7.68M
Stockholders Equity FY 2021 · Dec 31, 2019 −$6.92M
Total Liabilities FY 2021 · Dec 31, 2021 $8.18M
Total Liabilities FY 2021 · Dec 31, 2020 $7.69M
Current Assets FY 2021 · Dec 31, 2021 $1.02K
Current Assets FY 2021 · Dec 31, 2020 $1.02K
Total Assets FY 2021 · Dec 31, 2021 $6.3K
Total Assets FY 2021 · Dec 31, 2020 $11.58K
Eps Basic FY 2021 · Dec 31, 2021 −$0.04
Eps Basic FY 2021 · Dec 31, 2020 −$0.04
Net Income FY 2021 · Dec 31, 2021 −$1.01M
Net Income FY 2021 · Dec 31, 2020 −$774.46K
Operating Income FY 2021 · Dec 31, 2021 −$1.01M
Operating Income FY 2021 · Dec 31, 2020 −$740.61K